We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Ashleigh P. Barkans
Ashleigh P. Barkans
Products
PRODUCTS
Nutek Orthopaedics, Inc.
Ashleigh P. Barkans
Price:
$117.00
View
Maguire Enterprises, Inc.
Ashleigh P. Barkans
Price:
$117.00
View
Shippert Medical Technologies
Ashleigh P. Barkans
and
Alan P. Kurtzberg
Price:
$117.00
View
Parks Medical Electronics, Inc.
Ashleigh P. Barkans
and
Stanley B. Eugene
Price:
$117.00
View
Medtronic Navigation, Inc.
Ashleigh P. Barkans
,
Laura B. Kennedy
, and
Amanda S. Zorn
Price:
$117.00
View
Novarad Corporation
Ashleigh P. Barkans
Price:
$117.00
View
Encision, Inc.
Ashleigh P. Barkans
Price:
$117.00
View
Upcoming Events
05
Dec
Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing
07
Dec
Proactive Supplier Management Using Quality Agreements
13
Dec
FDA Inspection Overhaul: How Things Have Changed in 2023
14
Apr
MAGI 2024: The Clinical Research Conference
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
T-cell Malignancy From CAR-T Cell Immunotherapies Gets FDA Investigation
Vivos Sleep Apnea Oral Device Gets FDA Nod While Philips Wrestles With Yet Another CPAP Safety Issue
Novo Nordisk Battles Wegovy/Ozempic Pretenders and Faces Mounjaro’s Superior Study Results
Social, Emotional Risks Associated With Multi-Cancer Screening Discussed by Adcomm
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
